In summary, because phosphorylation of eIF4E is associated with resistance to cellular stress, with tumor development in mice models, and worse prognosis in human tumors, the use of specific inhibitors of eIF4E phosphorylation may be a promising approach in cancer treatment. This evidence concerns the gene EIF4E and neoplasm.